Literature DB >> 28050685

Giant prolactinomas: Multi-modal approach to achieve tumor control.

Ilan Shimon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28050685     DOI： 10.1007/s12020-016-1225-x

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  6 in total

Review 1.  Advances in the treatment of prolactinomas.

Authors:  Mary P Gillam; Mark E Molitch; Gaetano Lombardi; Annamaria Colao
Journal:  Endocr Rev       Date:  2006-05-26       Impact factor: 19.871

2.  Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis.

Authors:  Annamaria Colao; Giovanni Vitale; Paolo Cappabianca; Francesco Briganti; Antonio Ciccarelli; Michele De Rosa; Stefano Zarrilli; Gaetano Lombardi
Journal:  J Clin Endocrinol Metab       Date:  2004-04       Impact factor: 5.958

3.  Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas.

Authors:  Ilan Shimon; Ernesto Sosa; Victoria Mendoza; Yona Greenman; Amit Tirosh; Etual Espinosa; Vera Popovic; Andrea Glezer; Marcello D Bronstein; Moises Mercado
Journal:  Pituitary       Date:  2016-08       Impact factor: 4.107

4.  Giant prolactinomas: are they really different from ordinary macroprolactinomas?

Authors:  Etual Espinosa; Ernesto Sosa; Victoria Mendoza; Claudia Ramírez; Virgilio Melgar; Moisés Mercado
Journal:  Endocrine       Date:  2015-11-11       Impact factor: 3.633

Review 5.  Giant prolactinomas in women.

Authors:  Etienne Delgrange; Gerald Raverot; Marie Bex; Pia Burman; Bénédicte Decoudier; France Devuyst; Ulla Feldt-Rasmussen; Marianne Andersen; Dominique Maiter
Journal:  Eur J Endocrinol       Date:  2013-11-22       Impact factor: 6.664

Review 6.  Therapy of endocrine disease: the challenges in managing giant prolactinomas.

Authors:  Dominique Maiter; Etienne Delgrange
Journal:  Eur J Endocrinol       Date:  2014-02-17       Impact factor: 6.664
  6 in total
  3 in total

1.  Decrease of Proliferative Potential and Vascular Density of Giant Prolactinoma in Patients Treated with Cabergoline.

Authors:  Ludmila Astaf'eva; Ludmila Shishkina; Pavel Kalinin; Boris Kadashev; Galina Melnichenko; Dariia Tserkovnay; Oleg Sharipov
Journal:  Asian J Neurosurg       Date:  2020-05-29

2.  Clinical outcomes in male patients with lactotroph adenomas who required pituitary surgery: a retrospective single center study.

Authors:  Winnie Liu; Roula Shraiky Zahr; Shirley McCartney; Justin S Cetas; Aclan Dogan; Maria Fleseriu
Journal:  Pituitary       Date:  2018-10       Impact factor: 4.107

3.  Highly Aggressive and Radiation-Resistant, "Atypical" and Silent Pituitary Corticotrophic Carcinoma: A Case Report and Review of the Literature.

Authors:  Laura Flores; Richard Sleightholm; Beth Neilsen; Michael Baine; Andjela Drincic; William Thorell; Nicole Shonka; David Oupicky; Chi Zhang
Journal:  Case Rep Oncol       Date:  2019-02-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.